ANDROSTENEDIONE AS A PREDICTOR OF OVARIAN HYPERSTIMULATION SYNDROME

被引:11
作者
GUSTAFSON, O
CARLSTROM, K
NYLUND, L
机构
[1] Department of Obstetrics and Gynaecology, Karolinska Institute, Huddinge University Hospital
关键词
ANDROSTENEDIONE; GNRHA; OVARIAN HYPERSTIMULATION SYNDROME; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;
D O I
10.1093/oxfordjournals.humrep.a137770
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Serum concentrations of testosterone, 4-androstene-3,17-dione (androstenedione), dehydroepiandrosterone (DHA) and its sulphate and sex hormone-binding globulin (SHBG) were measured in 30 ovulatory women before and after down-regulation with gonadotrophin releasing-hormone analogue, prior to ovarian stimulation in a programme of in-vitro fertilization and embryo transfer. Nine of the women developed ovarian hyperstimulation syndrome (OHSS) while the others did not. Pretreatment values of androstenedione and the androstenedione:DHA ratios were higher and the testosterone:androstenedione ratios lower in the OHSS women. The decrease in androstenedione levels during down-regulation was greater and the absolute levels following down-regulation were lower in the OHSS group. Higher levels of SHBG and lower testosterone:SHBG ratios, an index of biologically active testosterone, were observed in the OHSS group. The isolated elevation in pretreatment androstenedione levels and the high SHBG levels make the OHSS group different from patients with polycystic ovarian disease. Pretreatment values of testosterone:androstenedione or testosterone/SHBG:androstenedione ratios and/or the decrease in androstenedione during down-regulation may be used as markers, prior to stimulation, for identifying women at risk of developing OHSS.
引用
收藏
页码:918 / 921
页数:4
相关论文
共 32 条
[1]
Balasch J., Carmona F., Llach J., Arroyo V., Jove L., Vanrell J.A., Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome, Hum. Reprod, 5, pp. 348-350, (1990)
[2]
Bardin C.W., Lipsett M.B., Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism of polycystic ovaries, J. Clin. Invest, 46, pp. 891-902, (1967)
[3]
Blankstein J., Shalev J., Saadon T., Kukia E.E., Rabinovici J., Pariente C., Lunenfeld B., Serr D.M., Mashiach S., Ovarian hyperstimulation syndrome: Prediction by number and size of preovulatory follicles, Fenil. Steril, 47, pp. 597-602, (1987)
[4]
Brody S., Carlstrom K., Lagrelius A., Lunell N.-O., Rosenborg L., Adrenocortical steroids, bone mineral content and endometrial condition in postmenopausal women, Maturitas, 4, pp. 113-122, (1982)
[5]
Brody S., Carlstrom K., Lagrelius A., Lunell N.-O., Rosenborg L., Serum levels of 4-androstene-3, 17-dione in menstruating and postmenopausal women. Evaluation of a radioimmunoassay and correlation with bone mineral content and endometrial pathology, Acta Obstet. Gynecol. Scand, 62, pp. 531-534, (1982)
[6]
Carlstrom K., Doberl A., Gershagen S., Rannevik G., Rasmussen T., Tobiassen T., Elevated peripheral levels of androgens and of some steroid sensitive proteins in patients with severe fibrocystic breast disease, Acta Obstet. Gynecol. Scand, 123, pp. 157-158, (1984)
[7]
Carlstrom K., Eriksson S., Rannevik G., Sex steroids and steroid binding proteins in female alcoholic liver disease, Acta Endocrinol, 111, pp. 75-79, (1986)
[8]
Carlstrom K., Rannevik G., Eriksson S., 4-Androstene-3, 17-dione (A-4) levels and ratios between A-4 and déhydroépiandrostérone (DHA) in plasma or serum: Sensitive but nonspecific markers of liver affection?, Advances in Steroid Analysis 90 Akademiai Kiado, pp. 413-418, (1991)
[9]
Carter C.D., Holland S.M., Alaghband-Zadeh J., Rayman G., Dorrington-Ward P., Wise P.H., Investigation of hirsutism: Testosterone is not enough, Ann. Clin. Biochem, 20, pp. 262-263, (1983)
[10]
Cumming D.C., Wall S.R., Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism, J. Clin. Endocrinol. Metab, 61, pp. 873-876, (1985)